Edgewise Pharma - Prakiraan wutah bathi resik saben saham kanggo taun ngarep EWTX

Logo korporat perusahaan Edgewise Therapeutics (EWTX)

Risk for Edgewise Therapeutics (EWTX) is linked to the search for new clinical trial leads. The trend in the company's EPS forecast indicates support, where -120.60 forms the current metric value. Stability is provided by massive investments in bioengineering and significant regulatory complexities in the development of neuromuscular drugs, which create a robust defensive barrier for the business.

Edgewise Pharma (EWTX): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 16.11.2026

Ringkesan rincian data analitis Edgewise Pharma (EWTX)

Analisis fundamental perusahaan:Edgewise Therapeutics Inc, EWTX
Produk dadi Edgewise Therapeutics Inc

The scale of ecosystem development for rare neuromuscular disease therapies at Edgewise Therapeutics (EWTX) is reflected in the forward net income trend. This metric aggregates analyst consensus forecasts for next year's earnings per share, allowing for an assessment of the company's ability to monetize innovations in muscle tissue protection and identifying the risks of inflated market expectations regarding business growth rates.

Pesaing Edgewise Therapeutics

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Jazz Pharmaceuticals|CYTK: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PTC Bio (PTCT)|SRRK - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Centessa Pharmaceuticals PLC CNTA|Dyne Pharma (DYN) - Prakiraan wutah bathi resik saben saham ing taun ngarep|RAPP - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Alumis Inc.|ZVRA: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Contineum Pharma CTNM|Prakiraan wutah bathi saben saham kanggo taun ngarep LRMR|Prakiraan wutah bathi resik saben saham ing taun ngarep Capricor Therapeutics CAPR|Prakiraan wutah bathi kanggo taun ngarep TRDA|Prakiraan wutah bathi saben saham kanggo taun ngarep Channel Therapeutics PTHS|Prakiraan wutah bathi kanggo taun ngarep MNOV (MediciNova)|Dinamika bathi saben saham sing diarepake ing taun ngarep SER|BTAI - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|promisneurosciences.com (PMN) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Apimeds (APUS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep AEON|Prakiraan wutah bathi resik saben saham kanggo taun ngarep NLS Pharma|Prakiraan wutah bathi resik saben saham ing taun ngarep bionomics.com.au BNOX|Prakiraan wutah bathi kanggo taun ngarep HUGE|RETA (Reata Pharma) - Dinamika bathi saben saham sing diarepake ing taun ngarep